Mechanisms of neurohormonal activation in chronic congestive heart failure:: pathophysiology and therapeutic implications

被引:35
|
作者
Dávila, DF [1 ]
Núñez, TJ [1 ]
Odreman, R [1 ]
de Dávila, CAM [1 ]
机构
[1] Univ Los Andes, Inst Invest Cardiovasc, Merida 5101, Venezuela
关键词
congestive heart failure; sympathetic nervous system; neurohormonal activation; low-pressure cardiac receptors; high-pressure carotid receptors; sympathetic afferents;
D O I
10.1016/j.ijcard.2004.08.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with chronic congestive heart failure have a sequential and incessant activation of those neurohormonal systems, which control body fluids, cardiac output and systemic blood pressure. Neurohormonal activation is initially selective and regional. Generalized activation is a late event in the natural history of congestive heart failure. Although the ultimate stimulus responsible for the activation of these neurohormonal systems is unknown, a decreased cardiac output and diminished effective blood volume have been proposed as the responsible mechanisms. However, extensive clinical and experimental research suggest that cardiac remodeling and loading of low-pressure cardiac receptors with sympathetic afferents could be the triggering events followed by unloading of high-pressure carotid receptors by decreased cardiac output and diminished effective blood volume. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 50 条
  • [32] Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease
    Bolger, AP
    Sharma, R
    Li, W
    Kalra, P
    Coats, AJS
    Anker, SD
    Pool-Wilson, PA
    Gatzoulis, MA
    EUROPEAN HEART JOURNAL, 2002, 23 : 621 - 621
  • [33] Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications
    Kim J.H.
    Shah P.
    Tantry U.S.
    Gurbel P.A.
    Current Heart Failure Reports, 2016, 13 (6) : 319 - 328
  • [34] Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications
    Si, Ke
    Wei, Chijing
    Xu, Lili
    Zhou, Yue
    Lv, Wenshan
    Dong, Bingzi
    Wang, Zhongchao
    Huang, Yajing
    Wang, Yangang
    Chen, Ying
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [35] Hyperkalaemia in Heart Failure—Pathophysiology, Implications and Therapeutic Perspectives
    Llubani R.
    Vukadinović D.
    Werner C.
    Marx N.
    Zewinger S.
    Böhm M.
    Current Heart Failure Reports, 2018, 15 (6) : 390 - 397
  • [36] Congestive heart failure: Diagnosis, pathophysiology, therapy, and implications for respiratory care
    Figueroa, MS
    Peters, JI
    RESPIRATORY CARE, 2006, 51 (04) : 403 - 412
  • [37] SPONTANEOUS NEUROHORMONAL FLUCTUATION IN CONGESTIVE-HEART-FAILURE
    KIRLIN, PC
    KOESTNER, CA
    DANSBY, CM
    WILLIS, PW
    CIRCULATION, 1986, 74 (04) : 446 - 446
  • [38] Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications
    Guazzi, M
    CLINICAL SCIENCE, 2000, 98 (06) : 633 - 641
  • [39] Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure
    Bergamini, Corinna
    Cicoira, Mariantonietta
    Rossi, Andrea
    Vassanelli, Corrado
    EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (05) : 444 - 452
  • [40] PATHOPHYSIOLOGY OF CONGESTIVE-HEART-FAILURE
    PARMLEY, WW
    CLINICAL CARDIOLOGY, 1992, 15 (09) : I5 - I12